WASHINGTON — A “voice biomarker” may be able to predict which patients have CAD or develop chest pain or ACS, according to findings presented at the American College of Cardiology Scientific Session.
For 108 patients (mean age, 59 years; 55% men; 57% with stable angina) clinically indicated for coronary angiography, researchers used an app (Vocalis Health) to make three 30-second voice recordings to establish a voice biomarker score, and calculated a voice biomarker value for each patient.
“This is not speech. This is the frequency of the voice that someone uses, like